Treatment of a tardive dyskinesia patient with temporomandibular disorder: a case report.
This case report presents a patient with tardive dyskinesia who also suffered from masticatory muscle pain and temporomandibular joint osteoarthrosis. The patient was treated with clozapine in gradually increasing doses and two injections of botulinum toxin type A one year apart. Involuntary movements of mandibular clenching and bruxing disappeared and pain was relieved to a great extent. Reappearances of dyskinetic movements and pain were observed during the follow-up period of 1.5 years.
Pekkan
Gurel
G
Department of Dentistry, Dumlupinar University, Merkez Kampus, Tavsanli Yolu 10. Km, 43270, Kutahya, Turkey. gurelp@gmail.com
Kilicoglu
Alev
A
Algin
Demet Ilhan
DI
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002012:Bruxism / Q000188:drug therapy* / Q000209:etiology; D003024:Clozapine / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000150:complications* / Q000188:drug therapy; D005157:Facial Pain / Q000188:drug therapy* / Q000209:etiology; D005500:Follow-Up Studies; D018756:GABA Antagonists / Q000627:therapeutic use; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010003:Osteoarthritis / Q000209:etiology; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy; D013705:Temporomandibular Joint Disorders / Q000188:drug therapy* / Q000209:etiology
D014150:Antipsychotic Agents; D018756:GABA Antagonists; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; D003024:Clozapine; D006220:Haloperidol